ABEO logo

ABEO
Abeona Therapeutics Inc

11,006
Mkt Cap
$307.49M
Volume
928,599.00
52W High
$7.54
52W Low
$4.00
PE Ratio
5.41
ABEO Fundamentals
Price
$5.39
Prev Close
$5.52
Open
$5.52
50D MA
$4.96
Beta
0.71
Avg. Volume
1.49M
EPS (Annual)
$1.01
P/B
1.86
Rev/Employee
$25,752.21
$182.10
Loading...
Loading...
News
all
press releases
Aberdeen Group plc Makes New $3.25 Million Investment in Abeona Therapeutics Inc. $ABEO
Aberdeen Group plc acquired a new position in shares of Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange...
MarketBeat·18d ago
News Placeholder
More News
News Placeholder
HC Wainwright Issues Pessimistic Outlook for ABEO Earnings
Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) - Equities researchers at HC Wainwright decreased their Q1 2026 EPS estimates for Abeona Therapeutics in a report released on Thursday, March 19th. HC Wainwright analyst R. Selvaraju now anticipates that the biopharmaceutical company will post ear...
MarketBeat·1mo ago
News Placeholder
Abeona Therapeutics (NASDAQ:ABEO) Earns Buy Rating from HC Wainwright
HC Wainwright reiterated a "buy" rating and issued a $20.00 price target on shares of Abeona Therapeutics in a research report on Thursday...
MarketBeat·1mo ago
News Placeholder
Abeona Therapeutics Q4 Earnings Call Highlights
Abeona Therapeutics (NASDAQ:ABEO) executives said the company is seeing growing patient demand for ZEVASKYN, an autologous cell-based gene therapy approved in April 2025 for adults and pediatric...
MarketBeat·1mo ago
News Placeholder
Abeona Therapeutics (NASDAQ:ABEO) Releases Quarterly Earnings Results, Misses Expectations By $0.01 EPS
Abeona Therapeutics (NASDAQ:ABEO - Get Free Report) issued its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($0.34) EPS for the quarter, missing analysts' consensus...
MarketBeat·1mo ago
News Placeholder
Abeona Therapeutics Inc. $ABEO Shares Sold by Boone Capital Management LLC
Boone Capital Management LLC decreased its holdings in shares of Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) by 59.9% during the third quarter, according to its most recent disclosure with...
MarketBeat·1mo ago
News Placeholder
Q4 EPS Forecast for Abeona Therapeutics Increased by Analyst
Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) - Stock analysts at HC Wainwright boosted their Q4 2025 EPS estimates for shares of Abeona Therapeutics in a research note issued on Tuesday...
MarketBeat·2mo ago
News Placeholder
Abeona Therapeutics Says ZEVASKYN Launch Is Back on Track, Eyes Profitability in 2026
Abeona Therapeutics (NASDAQ:ABEO) executives said the commercial launch of ZEVASKYN is gaining momentum after an early manufacturing-related delay, outlining progress on treatment center activation...
MarketBeat·2mo ago
News Placeholder
HC Wainwright Reaffirms "Buy" Rating for Abeona Therapeutics (NASDAQ:ABEO)
HC Wainwright reiterated a "buy" rating and issued a $20.00 price objective on shares of Abeona Therapeutics in a research report on Tuesday...
MarketBeat·2mo ago
News Placeholder
Abeona Therapeutics (ABEO) Projected to Post Earnings on Tuesday
Abeona Therapeutics (NASDAQ:ABEO) will be releasing its Q4 2025 earnings before the market opens on Tuesday, March 17. (View Earnings Report at...
MarketBeat·2mo ago
<
1
2
...
>

Latest ABEO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.